Medicare's $2,400 Drug Cap in 2027: 7 Changes to Check Before December 7

If you are on Medicare, here is the short answer: your out-of-pocket spending on covered prescription drugs is capped at $2,400 in 2027, up from $2,100 in 2026, and the choices you make before December 7, 2026 decide what you actually pay, because anything you change takes effect on January 1, 2027.

This article follows the video Medicare's $2,400 Drug Cap Starts Jan 1 — 7 Changes Before Dec 7 from Problem Solved, and every figure below comes from that video's own account of Medicare's announcements for 2027.

Key facts

  • Part D out-of-pocket cap: $2,400 in 2027, up from $2,100 in 2026; once reached, covered Part D drugs cost nothing more that year.
  • Maximum standard Part D deductible: $700 in 2027, up from $615; many plans charge less or waive it for cheap generics.
  • 15 more drugs get Medicare-negotiated prices on January 1, 2027, bringing the total to 25; Medicare projects about $685 million in enrollee savings.
  • Insulin stays capped at $35 a month for covered insulin; Social Security checks rise 3.6% in January, roughly $75 a month on average.
  • Medicare open enrollment runs October 15 through December 7, 2026; do nothing and your plan autorenews on 2027 terms.

What Changed for 2027

Change one is the cap itself: $2,400, up from $2,100. Change two is the deductible: the maximum standard Part D deductible rises to $700, up from $615, though many plans charge less and some waive the deductible for cheap generics, which makes it a real point of comparison between plans. Part D is the Medicare prescription-drug benefit, and a deductible is the amount you pay for covered drugs before the plan starts sharing the cost. Change three is the negotiated-price expansion: 10 drugs got negotiated prices in 2026 and 15 more join on January 1, 2027, including semaglutide, sold as Ozempic, Wegovy and Rybelsus, plus Trelegy Ellipta, Xtandi, Ibrance and Linzess, joining the 2026 list that includes Eliquis, Jardiance and Xarelto. Change four is the end of the temporary program that held down standalone Part D premiums in 2026, so the new premium line deserves a careful read rather than an assumption that it barely moved; Medicare projects the average standalone premium rises only slightly to about $36, but averages hide individual plans that jump much more. Change five is plan exits: several large insurers are cutting Medicare Advantage plans or leaving some counties entirely, so verify your plan still exists where you live. Change six is insulin, which stays capped at $35 a month for covered insulin. Change seven is the offset: Social Security checks rise 3.6% in January, roughly $75 a month on average, which partly offsets the Part B increase — though the 2027 Part B premium itself had not been announced when enrollment opened, and the video advises checking medicare.gov for the final number before deciding.

How the $2,400 Cap Actually Works

Since 2025, Medicare drug coverage has had a hard annual limit on what you personally pay for covered prescriptions, and in 2027 that limit is $2,400. Your deductible, your co-pays and your co-insurance for drugs on your plan's formulary all count toward the cap; a formulary is your plan's list of covered drugs, and a co-pay is a fixed amount you pay for a prescription while co-insurance is a percentage of its cost. Once the total you have paid reaches $2,400, you pay zero for covered Part D drugs for the rest of the calendar year — not a discount, zero. Three details decide whether this helps you or surprises you. First, it only counts drugs on your plan's formulary, so spending on a medication your plan does not list does not move you toward the cap, which is why checking your plan's drug list, not just the premium, is the single highest-value thing you can do before December 7. Second, timing matters: the cap resets every January 1, so if you take a specialty drug costing thousands a month you may hit the cap in February or March and pay nothing after, which means budgeting for the heavy months early rather than spreading evenly. Third, the payment-smoothing option lets you spread drug costs across the year in monthly installments instead of paying big amounts in the early months; it does not change your total, but for people on fixed incomes the cash-flow difference is real, so ask your plan about the monthly payment option when you review your coverage. Our earlier guide to the $2,100 cap in 2026 shows how the mechanics worked last year.

The 15 New Negotiated Prices — and Why Your Price May Differ

The headline that got the most attention this enrollment season is the drug list, and the $685 million projected saving is a real number from Medicare's own announcement, as the video stresses. But a negotiated price is not the same as your price. What you actually pay still depends on your specific plan: which tier the plan puts the drug on, whether the plan requires prior authorization or step therapy — approval steps before the drug is covered — and whether the drug is on your formulary at all. Two people on two different Part D plans can pay very different amounts for the same negotiated drug. The winning move is concrete: take every prescription you fill regularly, enter them into Medicare's Plan Finder tool, and compare your total annual cost across plans, not just the monthly premium, because Plan Finder shows the deductible, the co-pays per drug and the yearly total side by side. That single exercise, done once before December 7, answers the only question that matters: what do I pay, on my drugs, on my plan?

Three Traps That Cost Thousands

Trap one is autorenewal blindness: do nothing by December 7 and your plan renews automatically, but it renews with 2027's terms, while your insurer is required to send you an annual notice of change explaining exactly what moved — and most people never open it. Read it, and compare the new premium, the new deductible and whether your doctors and drugs are still covered, because accepting the renewal blind is, in the video's words, the most expensive default in American health insurance. Trap two is disappearing plans: if your plan is going away you will get a notice and you get to pick a new one during open enrollment, but if you miss the notice and the deadline you can end up scrambling in January with far fewer options, so confirm your plan still exists for your county before December 7. Trap three is the standalone drug-plan premium surprise, driven by the ending premium-stabilization subsidy described above. One related warning for people considering a switch: if you move from Medicare Advantage back to Original Medicare and want a Medigap supplement — the private policy that fills gaps in Original Medicare — acceptance is not guaranteed after your initial enrollment window unless you have guaranteed-issue rights, so understand the Medigap rules before you switch, not after. For the mistakes that catch the most people, see Medicare open enrollment 2027: 7 costly mistakes to avoid.

Who Benefits From This — and Who Does Not

People who take expensive brand-name or specialty drugs benefit most from the $2,400 ceiling, because they reach it early and then pay nothing more for covered prescriptions that year. People on one of the 15 newly negotiated drugs benefit on paper, and benefit in practice once they confirm the drug's tier and formulary status on their own plan. People on fixed incomes benefit from the monthly payment option, which smooths the heavy early months without changing the total. People whose main drug is not on their plan's formulary do not benefit from the cap at all, because that spending never counts toward it — for them, switching plans may matter more than the cap itself. People whose main cost is a high premium, or care outside drug coverage, do not benefit much either, because the cap covers neither. And people who never read their annual notice of change do not benefit, because they accept whatever their insurer changed. Help is free for all of these groups: every state has a State Health Insurance Assistance Program, known as SHIP, where trained counselors compare plans at no cost, and people with limited incomes should ask about Extra Help, the federal program that sharply reduces Part D costs for qualifying beneficiaries. For more on the channel behind the video, visit Problem Solved on YouTube.

Disclaimer: this article is general information about Medicare, not personal financial, medical or insurance advice. Plan terms vary by county and insurer; check medicare.gov, Plan Finder or a SHIP counselor for your own situation.

Frequently Asked Questions

What is the Medicare drug cap in 2027?

The cap is $2,400 in 2027, up from $2,100 in 2026: once what you have paid for covered Part D prescriptions reaches $2,400 in the calendar year, you pay nothing more for covered Part D drugs for the rest of that year. Your deductible, co-pays and co-insurance for drugs on your plan's formulary all count toward the cap, and the cap resets every January 1.

Who benefits most from the $2,400 cap?

People who take expensive brand-name or specialty drugs benefit most, because they reach the cap early in the year and then pay nothing more for covered prescriptions. People who take one of the 15 newly price-negotiated drugs also benefit, since Medicare projects about $685 million in enrollee out-of-pocket savings from those prices in 2027.

Who does not benefit, or for whom is the cap not enough?

The cap does not help with spending on drugs that are not on your plan's formulary, because that spending does not count toward it. It also does not cap your premiums, your medical care or drugs you buy outside the plan, so shoppers whose main cost is a high premium or uncovered drug still need to compare plans on total cost.

How do I start comparing plans before December 7?

First, open your plan's annual notice of change and read what actually changed for 2027: premium, deductible, drug list and network. Second, confirm your doctors, specialists and pharmacy are still in network. Third, enter every prescription you take into Medicare's Plan Finder and compare total annual cost across plans, not the monthly premium alone. Fourth, check any Medicare Advantage extra benefits honestly, confirming the details rather than the brochure headline.

Do negotiated prices mean I pay less for Ozempic?

Not automatically. A negotiated price is not the same as your price: what you actually pay still depends on your plan, which tier it puts the drug on, whether it requires prior authorization or step therapy, and whether the drug is on your formulary at all. Two people on two different Part D plans can pay very different amounts for the same negotiated drug, which is why running your own drugs through Plan Finder matters more than any headline.

What happens if I miss December 7?

If you do nothing by December 7, 2026, your plan renews automatically on 2027 terms, which may mean a new premium, a new drug list and a new network. If you are already in a Medicare Advantage plan, you get one more window, January 1 through March 31, to switch to another Advantage plan or return to Original Medicare. People in Original Medicare with a standalone drug plan generally do not get that second window, so their deadline is firmer.

Watch on YouTube

Problem Solved on YouTube